CFMS Conformis Inc

Price (delayed)

$0.82

Market cap

$149.63M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.3

Enterprise value

$75.25M

Sector: Healthcare
Industry: Medical Devices

Highlights

Conformis's quick ratio has surged by 101% YoY
The EPS rose by 35% year-on-year and by 12% since the previous quarter
Conformis's net income has increased by 13% YoY but it has decreased by 9% from the previous quarter
Conformis's debt has increased by 18% YoY
Conformis's revenue has decreased by 10% YoY and by 3.8% QoQ

Key stats

What are the main financial stats of CFMS
Market
Shares outstanding
182.48M
Market cap
$149.63M
Enterprise value
$75.25M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.71
Price to sales (P/S)
1.63
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.14
Earnings
Revenue
$66.12M
EBIT
-$24.01M
EBITDA
-$18.44M
Free cash flow
-$24.49M
Per share
EPS
-$0.3
Free cash flow per share
-$0.19
Book value per share
$0.48
Revenue per share
$0.5
TBVPS
$1.11
Balance sheet
Total assets
$146.02M
Total liabilities
$58.7M
Debt
$30.68M
Equity
$87.33M
Working capital
$99.21M
Liquidity
Debt to equity
0.35
Current ratio
4.34
Quick ratio
3.82
Net debt/EBITDA
4.03
Margins
EBITDA margin
-27.9%
Gross margin
49.4%
Net margin
-40%
Operating margin
-39.6%
Efficiency
Return on assets
-29%
Return on equity
-84%
Return on invested capital
-53.8%
Return on capital employed
-20.6%
Return on sales
-36.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CFMS stock price

How has the Conformis stock price performed over time
Intraday
1.23%
1 week
-4.65%
1 month
-3.53%
1 year
-10.87%
YTD
24.24%
QTD
-17.17%

Financial performance

How have Conformis's revenue and profit performed over time
Revenue
$66.12M
Gross profit
$32.67M
Operating income
-$26.19M
Net income
-$26.45M
Gross margin
49.4%
Net margin
-40%
Conformis's net income has increased by 13% YoY but it has decreased by 9% from the previous quarter
Conformis's net margin has decreased by 13% QoQ but it has increased by 3.1% YoY
Conformis's revenue has decreased by 10% YoY and by 3.8% QoQ
Conformis's operating margin has decreased by 9% YoY and by 8% QoQ

Growth

What is Conformis's growth rate over time

Valuation

What is Conformis stock price valuation
P/E
N/A
P/B
1.71
P/S
1.63
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.14
The EPS rose by 35% year-on-year and by 12% since the previous quarter
The stock's price to book (P/B) is 61% less than its last 4 quarters average of 4.4 and 56% less than its 5-year quarterly average of 3.9
The stock's price to sales (P/S) is 48% more than its last 4 quarters average of 1.1 but 14% less than its 5-year quarterly average of 1.9
Conformis's revenue has decreased by 10% YoY and by 3.8% QoQ

Efficiency

How efficient is Conformis business performance
CFMS's return on equity has surged by 58% since the previous quarter and by 49% year-on-year
CFMS's return on assets is up by 34% year-on-year and by 16% since the previous quarter
The company's return on invested capital fell by 16% QoQ and by 7% YoY
The return on sales has declined by 14% since the previous quarter

Dividends

What is CFMS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CFMS.

Financial health

How did Conformis financials performed over time
The total assets is 149% more than the total liabilities
The company's current ratio has surged by 151% QoQ and by 59% YoY
The total assets has soared by 130% YoY and by 104% from the previous quarter
Conformis's debt is 65% lower than its equity
Conformis's debt to equity has shrunk by 87% YoY and by 87% QoQ
Conformis's debt has increased by 18% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.